Starting today, you don’t need to wear a WHOOP to get WHOOP’s blood work.

That’s the headline from today’s announcement as WHOOP Advanced Labs — the company’s blood-testing and biomarker platform, powered by Quest Diagnostics is now available to anyone, membership or not.

WHOOP is also adding Galleri, GRAIL’s multi-cancer early detection test, to the Advanced Labs menu (for extra). All up, it can be one blood draw, and you’ll get screening for signals tied to more than 50 cancer types, run out of GRAIL’s lab in North Carolina.

On paper, this is a good-news story, and we’re not going to pretend it isn’t because pre-screening is great but according to the company, Advanced Labs panels start around $150 versus $3,000+ for comparable panels through a concierge or executive-physical setup. And yes, that’s a huge gap but how real is that cost? Other companies are offering similar but we’ve never seen the $3,000 figure.

WHOOP also says eight in 10 users reportedly walk away with a “meaningful health finding,” and more than half get something that’s worth a follow-up call to an actual doctor like elevated cardiovascular risk, insulin resistance, prediabetes, elevated Lp(a), hormone stuff.

Overall. Today’s press release is a bit fluffy and we thought some of the most interesting stuff wasn’t being explicitly said.

Wait — so am I a WHOOP customer or not?

For a company that heavily relies on subscriptions, you can now get your blood drawn, your biomarkers analyzed, and clinician-reviewed guidance delivered — all without ever strapping on a WHOOP or paying the membership fee. Genuinely no wearable required.

Except your results still land inside the WHOOP app.

So you’re not a hardware customer. You’re not a membership subscriber. But you are, unmistakably, a WHOOP data source. Your cardiovascular markers, your hormone panel, your cancer screening results — all of it now lives in WHOOP’s ecosystem, tied to a WHOOP account, viewed through a WHOOP-built interface. Interesting.

And that’s not a criticism so much as an honest description of what “membership-free” actually means here: WHOOP isn’t asking you to buy the strap anymore. It’s asking for something arguably more valuable — your health data — and it’s happy to let the hardware be optional to get it.

Is that a bad trade? Not necessarily. Quest is a legitimate, established lab network. A licensed provider orders the tests, a licensed clinician reviews the results. This isn’t some sketchy at-home drop-ship situation. But “you don’t need to be a member” and “you’re not a customer” are two very different claims, and WHOOP’s press release wants you to hear the first one and not think too hard about the second.

Why WHOOP is leaning into blood work right now

This move doesn’t happen in a vacuum, and the timing tells you something.

The screenless, subscription-free wearable is no longer WHOOP’s alone to sell. Garmin just launched its strapless, subscription-free option and Fitbit (under Google) launched theirs in the last few months too. The exact pitch WHOOP built its whole identity on (“just the sensor, none of the screen”) is now table stakes across the category, not a differentiator. So when your core hardware bet stops being unique, you go find the next moat.

For WHOOP, that moat is clinical-grade health data. A strap measures strain and recovery which is useful, but increasingly commoditized. A blood panel tells you things a wearable physically cannot: your actual insulin resistance, your actual Lp(a), whether something’s growing that shouldn’t be. And that’s a different category of value, and it’s much harder for a $200 screenless tracker from a competitor to replicate. Then bolting Galleri onto Advanced Labs as a genuine multi-cancer screening test pushes WHOOP further from “fitness tracker company” and further toward “health data platform,” which is a much bigger, much stickier business if they can pull it off.

Opening Advanced Labs to non-members fits the same logic. If the hardware differentiation is eroding, the smart move is to stop gating your best asset — the biomarker data pipeline behind hardware sales at all. Let anyone in. Get their blood data into your app and worry about converting them into full members later, once they’re already living inside your ecosystem and trusting your platform with the most sensitive data they have, because you gave it to them.

Our Thoughts

WHOOP Advanced Labs without a membership, plus a legitimate cancer screening option through Galleri, is a real expansion of access and for a lot of people, a useful one at a fraction of the traditional cost. We’re not going to knock that.

But don’t mistake “no membership required” for “no relationship required.” You’re still handing WHOOP your blood data and you’re still going to be using their app, under their account structure, inside their ecosystem. As the wearable itself stops being the differentiator, your very own blood is becoming the product WHOOP actually wants — and this launch is as much about building that data relationship with non-members as it is about democratizing access to good testing.

So yes, both things can be true, just go in with your eyes open as to what you’re giving up.